← Back to all trials
Completed
NCT05143554
Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting
Conditions: Chemotherapy-induced Nausea and Vomiting
Sex: All
Ages: 4 Years – 30 Years
Healthy volunteers: No
Phase: NA
Enrollment: 18
Sponsor: Medical College of Wisconsin
Location: Children's Wisconsin Hospital Milwaukee Wisconsin
Summary
This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.
Eligibility Criteria
Inclusion Criteria:
* Subjects who are scheduled to be admitted for chemotherapy administration and who will have at least one additional cycle of the same chemotherapy
* Chemotherapy regimens must include moderate and/or severe emetogenic chemotherapy
Exclusion Criteria:
* Significant developmental delays that would prohibit participation
* Infection or severe dermatological condition of ear
* Uncontrolled or severe infection
* No implanted electrical device is permitted
* Pregnancy
* Severe cardiopulmonary disease
* Diagnosis of hemophilia or other bleeding disorders
* Diagnosis psoriasis vulgaris
Source: ClinicalTrials.gov (NCT05143554). StuddyBuddy aggregates publicly available trial information.